(S)-1-Amino-3-methylbutylboronic acid pinanediol ester trifluoroacetate is a chiral, protected boronic acid derivative. Its structure features a pinanediol ester group protecting the boronic acid functionality, along with a primary amine group protected as a trifluoroacetate salt. The molecule contains a chiral center derived from the pinanediol moiety, which is crucial for its application in stereoselective synthesis. This compound is primarily employed as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of proteasome inhibitors. The boronic acid group, once deprotected, is a critical pharmacophore that interacts with the active site threonine residue of the proteasome. Its most notable application is in the synthesis of bortezomib (Velcade®), a first-in-class proteasome inhibitor used for the treatment of multiple myeloma and mantle cell lymphoma. The chiral pinanediol auxiliary ensures the correct stereochemistry of the final active pharmaceutical ingredient. As a specialized building block, it is not a general-purpose reagent but is essential for constructing the complex boronate core of specific therapeutics. Handling requires standard precautions for laboratory chemicals, and it should be stored under inert conditions to preserve the integrity of the boronic ester and amine functionalities.